Calam, Ashly Khate P.
HRN: 20-87-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2023
AMPICILLIN 500MG (VIAL)
01/05/2023
01/11/2023
IV
240mg
Q6
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes